Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin's Lymphoma - Aggressive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00807495
What this trial is testing

Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Diffuse Large B-cell LymphomaMantle Cell LymphomaBurkitt's Lymphoma+2 more
Millennium Pharmaceuticals, Inc. 48
Early research (Phase 1)UnknownNCT00053105
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Theradex
Large-scale testing (Phase 3)Study completedNCT01321541
What this trial is testing

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

Who this might be right for
Diffuse Large B-cell Lymphomade Novo DLBCLDLBCL Transformed From Indolent Lymphoma+1 more
CTI BioPharma 312
Early research (Phase 1)Study completedNCT02290951
What this trial is testing

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
Regeneron Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT00014209
What this trial is testing

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 77
Early research (Phase 1)Study completedNCT00323934
What this trial is testing

Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
TumorsNon Hodgkin's Lymphoma
Mirati Therapeutics Inc. 42
Testing effectiveness (Phase 2)UnknownNCT03456466
What this trial is testing

Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 122
Testing effectiveness (Phase 2)Study completedNCT00388531
What this trial is testing

Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

Who this might be right for
Lymphoblastic LeukemiaLymphoma
PETHEMA Foundation 10
Testing effectiveness (Phase 2)Study completedNCT00823719
What this trial is testing

Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large-Cell, Diffuse
GlaxoSmithKline 61
Testing effectiveness (Phase 2)Study completedNCT00006383
What this trial is testing

Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Inex Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT06834373
What this trial is testing

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

Who this might be right for
Large B-Cell Lymphoma With IRF4 RearrangementRecurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent ALK-Positive Large B-Cell Lymphoma+28 more
Mayo Clinic 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03625037
What this trial is testing

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

Who this might be right for
DLBCLHigh-grade B-cell Lymphoma (HGBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)+6 more
Genmab 666
Testing effectiveness (Phase 2)Study completedNCT01851551
What this trial is testing

Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL

Who this might be right for
Non-Hodgkin's LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma
Acrotech Biopharma Inc. 22
Testing effectiveness (Phase 2)Study completedNCT00413036
What this trial is testing

Revlimid in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin's
Celgene 217
Testing effectiveness (Phase 2)Study completedNCT01141712
What this trial is testing

Autologous Transplant in HIV Patients (BMT CTN 0803)

Who this might be right for
LymphomaHIV
Medical College of Wisconsin 43
Testing effectiveness (Phase 2)Study completedNCT00556452
What this trial is testing

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

Who this might be right for
LeukemiaHodgkin LymphomaNon-Hodgkin Lymphoma+2 more
University of Michigan Rogel Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT01994382
What this trial is testing

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

Who this might be right for
Follicular Lymphoma (FL/Indolent NHL)Aggressive NHL (a NHL)Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)+2 more
Alexion Pharmaceuticals, Inc. 260
Testing effectiveness (Phase 2)Study completedNCT00005964
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 59
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Study completedNCT00044551
What this trial is testing

Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Bayer 29
Next Page